The pervasive presence of “forever chemicals” in the American bloodstream isn’t simply a matter of widespread exposure – it appears to be subtly altering the aging process, and doing so differently in men than in women. A new study published in Frontiers in Aging isn’t sounding a direct alarm about dramatically shortened lifespans, but it is revealing a concerning link between exposure to per- and polyfluoroalkyl substances (PFAS) and accelerated epigenetic aging, particularly in men during a critical window of midlife. This isn’t about chronological age – the number of years lived – but biological age, a measure of how well our cells and tissues are functioning. The nuance here is crucial, and often lost in headlines proclaiming PFAS “speed up aging.”
The study, led by Xiangwei Li, a professor of epidemiology at Shanghai Jiao Tong University School of Medicine, re-analyzed data from the US National Health and Nutrition Examination Survey (NHANES) collected between 1999 and 2000. Researchers examined blood samples from 326 adults, assessing levels of 11 different PFAS chemicals and then used a sophisticated technique – epigenetic clocks – to estimate the age of various tissues based on patterns of DNA methylation. DNA methylation doesn’t change the DNA sequence itself, but it alters gene expression, essentially controlling which genes are “turned on” or “turned off.” These epigenetic clocks, validated against known aging markers, provide a snapshot of biological wear and tear. What Li and his team found was a strong correlation between PFAS exposure and a faster epigenetic age in men aged 50 to 65.
This article draws on reporting from CNN.
This sex-specific effect isn’t surprising, according to Jane Muncke, managing director and chief scientific officer at the Food Packaging Forum, who was not involved in the research. “The findings indicate a sex-specific effect that can be expected for chemicals that disrupt the endocrine system,” she explained. PFAS are known endocrine disruptors, meaning they interfere with the body’s hormone regulation. In men, this disruption can manifest as lower testosterone, impaired sperm quality, and increased cancer risks. Women, however, have natural mechanisms – menstruation, pregnancy, and breastfeeding – that facilitate the elimination of certain PFAS from the body, offering some degree of protection. This difference explains why the observed associations were weaker and less consistent in women, and why the effect appears concentrated in the midlife period for men.
It’s important to understand what the study didn’t find. The American Chemistry Council, representing the PFAS industry, was quick to point out that the research is “exploratory” and based on a relatively small sample size and older data. Tom Flanagin, the council’s senior director of communications, emphasized that the study “does not provide evidence that PFAS exposure causes aging.” This is a valid point – correlation does not equal causation. The researchers themselves acknowledge this limitation, stating their findings represent “puzzle pieces” contributing to our understanding of PFAS’s biological effects, not definitive proof of harm. However, dismissing the study as inconsequential overlooks the increasingly robust body of evidence linking PFAS to a range of adverse health outcomes.
The study also highlighted the potential impact of less-studied PFAS compounds. While legacy PFAS like PFOA and PFOS have received significant attention – and are now targeted for elimination under the Stockholm Convention – the researchers found that perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA) were particularly strong predictors of accelerated epigenetic aging in men. This is concerning because the chemical industry has developed numerous replacement PFAS chemicals, and their potential health effects remain largely unknown. The fact that these newer compounds appear to be biologically active suggests the problem isn’t simply about phasing out a few “bad actors,” but about the entire class of PFAS.
Acknowledging the limitations is crucial. The NHANES data is over two decades old, and PFAS levels in the population have likely changed since then. The study also relies on a single blood sample collected at one point in time, offering a limited snapshot of an individual’s cumulative PFAS exposure. Furthermore, epigenetic aging is a complex process influenced by numerous factors – genetics, lifestyle, diet – making it difficult to isolate the specific contribution of PFAS. Despite these caveats, the findings add to a growing body of evidence suggesting that PFAS exposure has subtle but potentially significant consequences for long-term health.
Looking ahead, researchers need to conduct longitudinal studies – following individuals over time – to determine whether accelerated epigenetic aging translates into earlier onset of age-related diseases. It’s also critical to investigate the health effects of the newer PFAS compounds and to develop more sensitive methods for assessing PFAS exposure. Perhaps most importantly, the focus must shift towards preventative measures. As Li notes, complete avoidance of PFAS is unrealistic, but reducing exposure through water filtration, mindful consumer choices, and robust regulatory action is essential. The question now isn’t just if PFAS are harmful, but how widespread the damage is, and what steps can be taken to mitigate the risks for future generations – particularly for men entering their 50s and 60s today.
